Moderna Stock Rallies. This Big Risk Just Got Eliminated.

Core Viewpoint - The company has settled a patent litigation related to its Covid-19 vaccine, which alleviates a significant overhang on its shares [1] Group 1 - The resolution of the patent litigation is expected to positively impact the company's stock performance by removing uncertainties associated with the legal dispute [1]